A Study to Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED)

Phase 3

Completed

• Conditions: Hyperlipidemia; Hypercholesterolemia; Hypertriglyceridemia

• Registration Number: NCT00093899
• Lead Sponsor: Organon and Co

Brief Summary

The purpose of this study is to assess the cholesterol lowering effects of an investigational drug in patients with mixed hyperlipidemia (high cholesterol and high triglycerides).

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2004-10-07
• Study First Submitted QC: 2004-10-07
• Study First Posted: 2004-10-08
• Study Start: 2004-11
• Primary Completion: 2005-09
• Study Completion: 2005-09
• Status Verified: 2022-02
• Last Update Submitted: 2024-08-12
• Last Update Posted: 2024-08-15

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 611

Inclusion Criteria

• Men and women 18-79 years of age with high cholesterol and high triglycerides.

Exclusion Criteria

• Individuals who do not meet specific cholesterol or triglyceride levels as required by the study.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Plasma LDL-C.

Secondary Outcome Measures

Name	Time	Method
Plasma HDL-C, non-HDL-C, and TG. Tolerability